CDH11 and breast carcinoma: Collectively, we showed that elevated CDH11 is associated with breast cancer metastatic and CSC-like phenotypes, and its monospecific antibody targeting is a putative effective metastasis-limiting therapeutic option for treatment of metastatic breast cancer.